Skip to main content

Gleason Group, Inc.

Position in ABBV — AbbVie Inc.

CIK 1822632 PROSPECT, KY

Position in ABBV

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$55,360
+$35,134 QoQ
Shares Held
220
+136.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#4,067
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Gleason Group, Inc. holds $4,846,851 across 10 Drug Manufacturers - General names. ABBV ranks #6 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ABBV
AbbVie Inc.
This page
220 $55,360

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,360 220
2026-03-31 $20,226 93
2025-12-31 $21,249 93
2025-09-30 $21,301 92
2025-06-30 $16,891 91
2025-03-31 $18,856 90
2024-12-31 $15,993 90
2024-09-30 $17,575 89
2024-06-30 $20,239 118
2024-03-31 $21,305 117
2023-12-31 $17,976 116
2023-09-30 $17,141 115
2023-06-30 $15,359 114
2023-03-31 $18,008 113
2022-12-31 $4,848 30
2022-09-30 $20,534 153
2022-06-30 $4,135 27
2022-03-31 $4,376 27
2021-12-31 $3,655 27
2021-09-30 $2,912 27
2021-06-30 $2,928 26
2021-03-31 $2,813 26
2020-12-31 $2,785 26
2020-09-30 $45,021 514
2020-06-30 $49,875 508
2020-03-31 $38,247 502